Fold Holdings, Inc. Class A Common Stock (FLD)vsNomura Holdings Inc ADR (NMR)
FLD
Fold Holdings, Inc. Class A Common Stock
$0.87
-8.43%
FINANCIAL SERVICES · Cap: $33.11M
NMR
Nomura Holdings Inc ADR
$8.41
-2.77%
FINANCIAL SERVICES · Cap: $25.46B
Smart Verdict
WallStSmart Research — data-driven comparison
Nomura Holdings Inc ADR generates 7154517% more annual revenue ($2.17T vs $30.30M). NMR leads profitability with a 16.7% profit margin vs -164.6%. NMR earns a higher WallStSmart Score of 70/100 (B-).
FLD
Hold38
out of 100
Grade: F
NMR
Strong Buy70
out of 100
Grade: B-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 1622.0% YoY
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Revenue surging 27.5% year-over-year
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -137.2% — below average capital efficiency
Revenue declined 21.1%
4.5% earnings growth
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : FLD
The strongest argument for FLD centers on Price/Book, EPS Growth.
Bull Case : NMR
The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.
Bear Case : FLD
The primary concerns for FLD are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : NMR
The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.
Key Dynamics to Monitor
FLD profiles as a turnaround stock while NMR is a growth play — different risk/reward profiles.
NMR carries more volatility with a beta of 0.61 — expect wider price swings.
NMR is growing revenue faster at 27.5% — sustainability is the question.
FLD generates stronger free cash flow (-7M), providing more financial flexibility.
Bottom Line
NMR scores higher overall (70/100 vs 38/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fold Holdings, Inc. Class A Common Stock
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Fold Holdings, Inc. (FLD) is an innovative biotechnology company dedicated to advancing therapies for severe genetic and rare diseases through its pioneering research initiatives. With a robust product pipeline fortified by proprietary technologies and strategic collaborations, Fold is well-positioned to capitalize on emerging market opportunities. Its commitment to scientific excellence and patient-focused solutions underscores its potential for sustainable growth and value creation, making FLD an attractive investment prospect in the rapidly evolving healthcare sector.
Visit Website →Nomura Holdings Inc ADR
FINANCIAL SERVICES · CAPITAL MARKETS · USA
Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.
Compare with Other CAPITAL MARKETS Stocks
Want to dig deeper into these stocks?